Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in Waldenstrom's Macroglobulinemia
NCT00165295Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Sep 2005
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sildenafil in Waldenström macroglobulinemia (WM), sponsored by Dana-Farber Cancer Institute. Started Sep 2005; status: completed.
02
Drugs
sildenafil
03
Conditions
Waldenström macroglobulinemia (WM)
Beyond the preview
Go deeper on NCT00165295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00165295.